Guangdong Raynovent Biotech Co., Ltd.

Medshine Discovery Inc.

Citrix Systems, Inc.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Harbin Zhenbao Pharmaceutical Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group Go., Ltd.

Cheng Xie

Kevin X Chen

Shuhui Chen

Jian Li

Jian Xiong

Peng Li

Chaofeng Long

Xiaoxin Chen

Jingjing Wang

Fang Liu

Guoping Hu

Xuanjia Peng

Zhaoguo Chen

Yanxin Yu

Xinde Chen

Xiquan Zhang

Zhengxia Chen

Xin Tian

Aiming Zhang

Zhuowei Liu

Xiongbin Xu

Guibai Liang

Kai Zhou

Fei Sun

Zhen Gong

Meibi Dai

Zhifei Fu

Boyu Hu

Xiaofei Wang

Linghui Wu

Zhen Zeng

Jian Wei Li

Zhengwei Li

Jiangpeng Liao

Chengwu Liu

Fen Jiang

Yang Zhang

Xuejin Zhang

Zhulian Jiang

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Anti-influenza virus pyrimidine derivatives

The present invention relates to a group of pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and an application thereof in the preparation of a drug that serves as an HER2 inhibitor. Specifically, the present invention relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.

Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof

Anti-influenza virus pyrimidine derivative

Disclosed in the present invention are a crystal form of a [1,2,4]triazolo[1,5-c]pyrimidine compound and a preparation method thereof. Further disclosed is a use of the crystal form in the preparation of a medicament for treating Areceptor related diseases. 

Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

Disclosed are a crystal form and a salt form of a pyrazolopridine compound, and a preparation method therefor. Further included is the use of the crystal form in preparing anti-influenza virus drugs.

Crystal form and salt form of pyridoimidazole compound and preparation method therefor

A borate compound of an azetidine derivative, relating in particular to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a tautomer thereof, a stereoisomer thereof or a geometric isomer thereof, as well as a use thereof in the preparation of a drug used for the treatment or prevention of multiple myeloma. 

Borate of azetidine derivative

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. 

Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to Areceptor. The R, R, R, ring A, ring B, n, and m are as defined in the specification. 

[1,2,4]triazolo[1,5-c]pyrimidine derivative as Areceptor inhibitor

Disclosed in the present application are a compound represented by formula (I), or a pharmaceutically acceptable salt, a tautomer thereof, a stereoisomer thereof, or a geometrical isomer thereof, and uses thereof in the preparation of drugs for treating or preventing multiple myeloma. 

Azetidine derivative

Described embodiments provide a method, computer program product, and computer system for generating, by a computing device, a data file including at least one property from a first cascading style sheet (CSS) file, the at least one property defining a scripting language object. A scripting language file may be generated, the scripting language file may include a scripting language variable for the scripting language object. A second CSS file may be generated by replacing the at least one property from the data file with the scripting language variable of the scripting language file. An element of a webpage referenced by the scripting language object may be rendered based upon, at least in part, the scripting language variable of the second CSS file.

System and method for using a scripting language to dynamically style a cascading style sheet

The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II): 

Tyrosine kinase inhibitor and pharmaceutical composition comprising same

FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable salts or tautomers thereof are specifically disclosed.

Vinyl compounds as FGFR and VEGFR inhibitors

Growing community of inventors

Shanghai, China

Cheng Xie